Historically, BPH has been treated with medication or an invasive surgical procedure known as transurethral resection of the prostate (TURP). Medication is a costly alternative that can stop working over time and has potential side effects that can increase the need to remain on medication. Invasive surgery is associated with higher risks and complications, such as impotence and incontinence, and requires a five day hospital stay and four to six week recovery
Now, men with BPH have the opportunity to choose a minimally invasive surgical treatment known as GreenLight™ Laser Therapy. The treatment is a quick, outpatient procedure that delivers immediate and dramatic symptom relief without the side effects or expense of medication or the risks associated with invasive surgery. The most common side effects associated with GreenLight Laser Therapy are dysuria and hematuria. These side effects tend to be mild and short lived. See your urologist for details
- GreenLight Laser Therapy is a minimally invasive outpatient surgical treatment option for BPH that combines the effectiveness of TURP, the traditional surgical procedure, with fewer side effects.
- GreenLight uses laser energy to remove enlarged prostate tissue. This results in an open channel for urine to flow through, but with fewer risks of sexual and other side-effects common with TURP.
- More than 375,000 patients have been treated with GreenLight worldwide.
- GreenLight offers a definitive, long-lasting solution for patients with BPH.
- GreenLight is a quick, outpatient procedure that delivers immediate and dramatic symptom relief without the side effects or expense of medication or the risks associated with invasive surgery.
- Most patients return home a few short hours after the procedure and can return to normal, nonstrenuous activities within days.
- Of the BPH treatment options available, GreenLight has the widest patient selection and is an option for most patients suffering from an enlarged prostate.
- GreenLight’s safety and efficacy has been established in 400 clinical articles and abstracts.